Eosinopenia: Is it a good marker of sepsis in comparison to procalcitonin and C-reactive protein levels for patients admitted to a critical care unit in an urban hospital?

Journal of Critical Care

Volumn 25, Issue 4, 2010, Pages 570-575

  Shaaban, Hamid ^a   Daniel, Sunil ^a   Sison, Raymond ^a   Slim, Jihad ^a   Perez, George ^a  

^a ST MICHAEL S MEDICAL CENTER   (United States)

Author keywords

C reactive protein; Eosinopenia; Procalcitonin; Sepsis; Septic shock; Systemic inflammatory response syndrome;

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; EOSINOPENIA; EOSINOPHIL COUNT; FEMALE; HORMONE BLOOD LEVEL; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; URBAN AREA;

AGED; AGRANULOCYTOSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; EOSINOPHILS; FEMALE; HOSPITALS, URBAN; HUMANS; INTENSIVE CARE UNITS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; SENSITIVITY AND SPECIFICITY; SEPSIS;

EID: 78649446943     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2010.03.002     Document Type: Article

References (26)

1. Curtis N.S., Wes S. New concepts in sepsis. Curr Opin Crit Care 2002, 8:465-472.
2. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992, 101:1644-1655.
3. Simon C.E. A Manual of Clinical Diagnosis 1922, 53. Henry Klimpton, London.
4. Abidi K., Khoudri I., Belayachi J., Madani N., Zekraoui A., Zeggwagh A.A., et al. Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units. Crit Care 2008, 12:R59.
5. Rey C., Los Arcos M., Concha A., Medina A., Prieto S., Martinez P., et al. Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children. Intensive Care Med 2007, 33:477-484.
6. Luzzani A., Polati E., Dorizzi R., Rungatscher A., Pavan R., Merlini A. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med 2003, 31:1737-1741.
7. Brunkhorst F.M., Eberhard O.K., Brunkhorst R. Discrimination of infectious and non infectious causes of early acute respiratory distress syndrome by procalcitonin. Crit Care Med 1999, 27:2172-2176.
8. Aouifi A., Piriou V., Bastien O., Blanc P., Bouvier H., Evans R., et al. Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients. Crit Care Med 2000, 28:3171-3176.
9. Brunkhorst F.M., Wegscheider K., Forycki Z.F., Brunkhorst R. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis and septic shock. Crit Care 1999, 3:95.
10. Muller B., Becker K.L., Schachinger H., Rickenbacher P.R., Huber P.R., Zimmerli W., et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000, 28:977-983.
11. Reinhart K., Meisner M., Hartog M. Procalcitonin as a marker of the systemic inflammatory response to infection. Intensive Care Med 2000, 26:1193-1200.
12. Harbarth S., Holeckova K., Froidevaux C., Pittet D., Ricou B., Grau G.E., et al. Geneva Sepsis Network: diagnosis value of procalcitonin, interleukin-6 and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001, 3:396-402.
13. BalcI C., Sungurtekin H., Gurses E., Sungurtekin U., Kaptanoglu B. Usefulness of procalcitonin for diagnosis of sepsis in intensive care unit. Crit Care 2003, 7:85-90.
14. Christ-Crain M., Jaccard-Stolz D., Bingisser R., Gencay M.M., Huber P.R., Tamm M., et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004, 363:600-607.
15. Gibot S., Kolopp-Sarda M.N., Béné M.C., Cravoisy A., Levy B., Faure G.C., et al. Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med 2004, 141:9-15.
16. Bass D.A., Gonwa T.A., Szejda P., Cousart M.S., DeChatelet L.R., McCall C.E. Eosinopenia of acute infection: production of eosinopenia by chemotactic factors of acute inflammation. J Clin Invest 1980, 65:1265-1271.
17. Zappert J. Ueber das Vorkommen der Eosinophilen Zellen in menschlichen Blute. Z Klin Med 1893, 23:227-308.
18. Dalton A.J., Selye H. The blood picture during the alarm reaction. Folia Haematol 1939, 62:397-407.
19. Gross R. The Eosinophils in Physiology and Pathology of the Leukocytes 1962, 1-22. Grune & Stratton Inc, New York. H. Braunsteiner, D. Zucker-Franklin (Eds.).
20. Gil H., Magy N., Mauny F., Dupond J.L. Value of eosinopenia in inflammatory disorders: an 'old' marker revisited. Rev Med Interne 2003, 24:431-435.
21. Irwin and Rippe Intensive care medicine 2008, 6th ed.
22. Dorizzi R.M., Polati E., Sette P., Ferrari A., Rizzotti P., Luzzani A. Procalcitonin in the diagnosis of inflammation in intensive care units. Clin Biochem 2006, 39:1138-1143.
23. Castelli G.P., Pognani C., Meisner M., Stuani A., Bellomi D., Sgarbi L. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care 2004, 8:R234-R242.
24. Suprin K., Camus C., Gacoucin A., Le Tulzo Y., Lavoue S., Feuillu A., et al. Procalcitonin: a valuable indicator of infection in a medical ICU?. Intensive Care Med 2000, 26:1232-1238.
25. Rothenberg M.E. Eosinophilia. N Engl J Med 1998, 338:1592-1600.
26. Vincent J.L., Sakr Y., Sprung C.L., Ranieri V.M., Reinhart K., Gerlach H., et al. Sepsis Occurrence in Acutely Ill Patients Investigators: Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006, 34:344-353.